Patent details

Basic Information

Publication number:

EP1786785

PCT Application Number:

PCT/IB/2005/002837

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP057797359

PCT Publication Number:

WO/2006/021884

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ENANTIOMERICALLY PURE AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS

French Title of Invention:

COMPOSES D'AMINOHETEROARYLE ENANTIOMERIQUEMENT PURS UTILISES COMME INHIBITEURS DE PROTEINE KINASE

German Title of Invention:

ENANTIOMERENREINE AMINOHETEROARYL-VERBINDUNGEN ALS PROTEINKINASEHEMMER

SPC Number:

92155

Dates

Filing date:

15/08/2005

Grant date:

07/04/2010

EP Publication Date:

07/04/2010

PCT Publication Date:

02/03/2006

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/05/2007

EP B1 Publication Date:

07/04/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

15/08/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/03/2023

 

 

Name:

PFIZER INC.

Address:

66 Hudson Boulevard East, NY 10001-2192, New York, United States (US)

History of Owners

From:

15/08/2005

To:

14/03/2023

Name:

Pfizer Inc.

Address:

235 East 42nd Street, New York, NY 10017, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

07/04/2010

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

PAIRISH Mason A., Pfizer Global Reserch and Dev.

Address:

United States (US)

2

Name:

MENG Jerry J., Pfizer Global Reserch and Dev.

Address:

United States (US)

3

Name:

NAMBU Mitchell D., Pfizer Global Reserch and Dev.

Address:

United States (US)

4

Name:

CUI Jingrong J., Pfizer Global Reserch and Dev.

Address:

United States (US)

5

Name:

TRAN-Dube M. B. , Pfizer Global Reserch and Dev.

Address:

United States (US)

6

Name:

JIA Lei, Pfizer Global Reserch and Dev.

Address:

United States (US)

7

Name:

SHEN-Hong Pfizer Global Reserch and Dev.

Address:

United States (US)

8

Name:

KUNG Pei-Pei, Pfizer Global Reserch and Dev.

Address:

United States (US)

9

Name:

FUNK Lee A., Pfizer Global Reserch and Dev.

Address:

United States (US)

Priority

Priority Number:

605086 P

Priority Date:

26/08/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 241/20;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2023/05

Publication date:

04/04/2023

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20230000113A

Date Registered:

14/03/2023

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

changement d'adresse

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

PFIZER INC.

Address:

66 Hudson Boulevard East, NY 10001-2192, New York, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

11/07/2024

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MASTER DATA CENTER INC (ex Clarivate Analytics)

Filing date	Document type	Number of pages
16/03/2023	Outgoing Correspondence	3
14/03/2023	Request For Change	1
14/03/2023	Request For Change	1